Status:
COMPLETED
Electrical Impedance Tomography for the Assessment of Neurological Disease
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Dartmouth College
Conditions:
Neuromuscular Disease Patients
Central Neurological Disease Patients
Eligibility:
All Genders
21-80 years
Brief Summary
Overview of study. This is an observational study that is intended to provide the first in-human data using EIT as a biomarker of muscle health in neuromuscular conditions. We will seek patients with ...
Detailed Description
1. Overview of study. This is an observational study that is intended to provide the first in-human data using EIT as a biomarker of muscle health in neuromuscular conditions. We will seek patients wi...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Age 21 to 80 years
Exclusion
- Generalized neuromuscular disease or debilitated state due to underlying medical disease such as heart failure or malignancy
- Neuromuscular disease patients:
- Inclusion criteria:
- Age 21 to 80 years;
- History of awell-defined, localized or generalized neuromuscular condition producing weakness or muscle atrophy, including disuse atrophy.
- Exclusion criteria:
- 1\. Multiple generalized neuromuscular conditions.
- Central neurological disease patients:
- Inclusion criteria:
- Age 21 to 80 years;
- History of a well-defined disorder affecting the central nervous system that impacts motor function, including stroke, Parkinson's disease, dystonia, and multiple sclerosis
- Exclusion criteria:
- 1\. Multiple generalized neuromuscular conditions.
Key Trial Info
Start Date :
June 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 23 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05238038
Start Date
June 28 2019
End Date
August 23 2023
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215